Gainesville, FL, United States of America

Hank Wohltjen

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: University of Florida Research Foundation Inc., Xhale, Inc.. Active years: 2021.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hank Wohltjen: Innovator in Medication Adherence Monitoring

Introduction

Hank Wohltjen is a notable inventor based in Gainesville, Florida. He has made significant contributions to the field of medication adherence through his innovative designs and concepts. His work focuses on improving patient compliance with medication regimens, which is crucial for effective healthcare outcomes.

Latest Patents

Hank Wohltjen holds a patent for a Medication Adherence Monitoring Device. This invention, known as the Self Monitoring And Reporting Therapeutics (SMART®), provides a flexible system for monitoring medication adherence. The device allows for short-term, intermediate-term, and long-term monitoring, ensuring that patients can effectively manage their medication schedules.

Career Highlights

Throughout his career, Hank has worked with esteemed organizations such as the University of Florida Research Foundation and Xhale, Inc. His experience in these institutions has contributed to his expertise in developing innovative healthcare solutions.

Collaborations

Hank has collaborated with notable colleagues, including Donn Dennis and Matthew M Booth. These partnerships have enhanced his research and development efforts in the field of medication adherence.

Conclusion

Hank Wohltjen's contributions to medication adherence monitoring exemplify the importance of innovation in healthcare. His patented device represents a significant advancement in ensuring that patients adhere to their medication regimens effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…